Spruce Biosciences annual current ratio
2019
2020
2021
2022
2023
2024
2025
Spruce Biosciences Current Ratio Growth & History (SPRB)
Spruce Biosciences's current ratio was 5.17 for fiscal 2025.
View full Spruce Biosciences company overviewSpruce Biosciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 5.17 | 2.27 | +78.19% |
| 2024 | 2024-12-31 | 2.90 | −1.28 | −30.58% |
| 2023 | 2023-12-31 | 4.18 | −2.54 | −37.82% |
| 2022 | 2022-12-31 | 6.72 | −3.64 | −35.16% |
| 2021 | 2021-12-31 | 10.36 | −6.07 | −36.95% |
| 2020 | 2020-12-31 | 16.43 | 15.35 | +1419.65% |
| 2019 | 2019-12-31 | 1.08 | — | — |
Spruce Biosciences quarterly current ratio
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 9.23 | 6.63 | +254.93% |
| Q1 2026 | 2026-03-31 | 4.67 | 2.72 | +139.28% |
| Q4 2025 | 2025-12-31 | 5.17 | 2.27 | +78.19% |
| Q3 2025 | 2025-09-30 | 1.54 | −3.82 | −71.28% |
| Q2 2025 | 2025-06-30 | 2.60 | −2.57 | −49.76% |
| Q1 2025 | 2025-03-31 | 1.95 | −2.72 | −58.19% |
| Q4 2024 | 2024-12-31 | 2.90 | −1.28 | −30.58% |
| Q3 2024 | 2024-09-30 | 5.36 | 0.77 | +16.68% |
| Q2 2024 | 2024-06-30 | 5.17 | −0.29 | −5.24% |
| Q1 2024 | 2024-03-31 | 4.67 | −1.30 | −21.78% |
| Q4 2023 | 2023-12-31 | 4.18 | −2.54 | −37.82% |
| Q3 2023 | 2023-09-30 | 4.59 | −3.17 | −40.83% |
| Q2 2023 | 2023-06-30 | 5.46 | −4.09 | −42.85% |
| Q1 2023 | 2023-03-31 | 5.97 | −4.63 | −43.71% |
| Q4 2022 | 2022-12-31 | 6.72 | −3.64 | −35.16% |
| Q3 2022 | 2022-09-30 | 7.76 | −2.60 | −25.09% |
| Q2 2022 | 2022-06-30 | 9.55 | −6.40 | −40.13% |
| Q1 2022 | 2022-03-31 | 10.60 | −11.52 | −52.08% |
| Q4 2021 | 2021-12-31 | 10.36 | −6.07 | −36.95% |
| Q3 2021 | 2021-09-30 | 10.37 | 3.07 | +42.05% |
| Q2 2021 | 2021-06-30 | 15.96 | — | — |
| Q1 2021 | 2021-03-31 | 22.13 | — | — |
| Q4 2020 | 2020-12-31 | 16.43 | 15.35 | +1419.65% |
| Q3 2020 | 2020-09-30 | 7.30 | — | — |
| Q4 2019 | 2019-12-31 | 1.08 | — | — |
Spruce Biosciences current ratio trends
Over the last five fiscal years, Spruce Biosciences's current ratio decreased from 16.43 to 5.17, a change of −11.26. The latest reported quarter, Q2 2026, shows 9.23.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Spruce Biosciences source filings ↗